Archive ready

一般財団法人化学及血清療法研究所が製造販売する沈降精製百日せきジフテリア破傷風不活化ポリオ(セービン株)混合ワクチンについて|厚生労働省

https://www.mhlw.go.jp/stf/houdou/0000105418.html
April 6, 2026 at 03:01 PM JSTThe archive page, viewer, and downloads use this saved version.
April 6, 2026 at 03:01 PM JST·www.mhlw.go.jp

Bundle the HTML, screenshot, summaries, and metadata into one ZIP file. The first export request adds an external RFC 3161 timestamp before download.

Saved page

一般財団法人化学及血清療法研究所が製造販売する沈降精製百日せきジフテリア破傷風不活化ポリオ(セービン株)混合ワクチンについて|厚生労働省

Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.

StartedApril 6, 2026 at 03:01 PM JST

This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.

The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.

About this pageAI generated

This page announces the Ministry of Health, Labour and Welfare's decision regarding a quadrivalent vaccine "Quatrovac" manufactured by the Institute of Immunological Science. Following discovery of discrepancies between approved specifications and actual manufacturing practices, the ministry had requested a voluntary suspension of shipments in September. After detailed review, authorities determined no significant quality or safety issues existed. The Infectious Diseases Division of the Health Science Council recommended resuming shipments to prevent vaccine supply shortages. Consequently, the ministry lifted the shipment suspension on February 26, 2016.

一般財団法人化学及血清療法研究所が製造販売する沈降精製百日せきジフテリア破傷風不活化ポリオ(セービン株)混合ワクチンについて|厚生労働省 - Saved screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.